Juvenile dermatomyositis.

Area of Science:

• Pediatric Rheumatology
• Immunology
• Dermatology

Background:

• Juvenile dermatomyositis (JDM) is a rare idiopathic inflammatory disease affecting children under 16.
• It primarily targets skin and muscles, with an incidence of approximately 1 in 1 million children.
• Diagnosis relies on established criteria, differentiating it from other myopathies and connective tissue diseases.

Purpose of the Study:

• To provide a comprehensive overview of Juvenile Dermatomyositis (JDM).
• To discuss diagnostic criteria, differential diagnoses, and potential complications.
• To review current and emerging treatment strategies for JDM.

Main Methods:

• Review of existing literature and diagnostic criteria for JDM.
• Discussion of clinical manifestations, including typical and atypical presentations.
• Analysis of treatment approaches, including standard care and investigational therapies.

Main Results:

• JDM diagnosis requires ruling out other conditions; Bohan and Peter criteria are foundational.
• While typically affecting skin and muscles, JDM can involve other organs and lead to complications like calcinosis and glucose intolerance.
• Adult JDM rarely associates with malignancy, unlike adult-onset dermatomyositis.

Conclusions:

• JDM necessitates specialized pediatric center management for accurate assessment and treatment.
• Corticosteroids and physiotherapy are mainstays, with ongoing trials for immunosuppressive/immunomodulatory drugs.
• Most patients achieve remission, though relapses are common, highlighting the need for effective long-term management.